Centogene Strengthens Presence in Abu Dhabi by Acquiring Pearl Medical Analysis Laboratory
Abu Dhabi, United Arab Emirates – Centogene, a prominent player in precision medicine and genetic diagnostics, has announced its acquisition of Pearl Medical Analysis Laboratory (Pearl Lab), a licensed genetics and reproductive testing facility in Abu Dhabi. This strategic move allows Centogene to manage and operate Pearl Lab as an independent diagnostics provider, integrating it into its global diagnostics platform.
Expanding Access to Genetic Testing
The acquisition enhances Centogene’s footprint in the Middle East, significantly increasing access to advanced reproductive and personalized genetic testing. This development is particularly beneficial for fertility clinics, women’s health centers, hospitals, and physicians throughout the region. By leveraging Pearl Lab’s established presence alongside Centogene’s global expertise, the partnership aims to improve the quality and accessibility of genetic diagnostics.
The laboratory will offer an expanded range of services, including carrier screening, prenatal diagnostics, and preimplantation genetic testing. These services will be delivered locally, adhering to the highest quality standards and with reduced turnaround times. Centogene’s scientific platform, supported by a team of experienced geneticists and counselors, will provide clinicians and patients with enhanced access to advanced genetic care and expert guidance throughout the testing process.
Strategic Advisory Role
Cedro Strategy served as the exclusive advisor to Olive Rock Partners during this transaction. The firm played a crucial role in structuring the deal, overseeing the process from inception to completion, and coordinating the legal, financial, and operational aspects involved in the acquisition.
David Jiménez, Chief Executive Officer of Centogene, expressed satisfaction with the transaction, highlighting the constructive collaboration with Olive Rock Partners. He noted that this agreement underscores Centogene’s long-term commitment to the Middle East. It represents a significant advancement in making precision medicine capabilities more accessible to reproductive health and women’s health centers, ultimately benefiting patients in the region.
Future of Reproductive and Genetic Health
Abdullah Shahin, Founding Partner of Olive Rock Partners, emphasized the critical role Pearl Lab will play in the future of reproductive and genetic health in the region. He expressed confidence that Centogene’s scientific depth and international experience would facilitate the laboratory’s growth.
The acquisition reflects the UAE’s ongoing emergence, particularly Abu Dhabi, as a key hub for advanced healthcare, precision medicine, and fertility care. Rayan Salam, Founder and CEO of Cedro Strategy, remarked on the transformative impact of precision medicine on medical outcomes and patient experiences. He noted that Centogene’s extensive genetic database and regional expertise would directly benefit the local population from its base in Abu Dhabi.
Centogene’s Regional Expertise
Centogene has been active in the Middle East for nearly two decades, building substantial expertise in the region’s genetic landscape through collaborations with healthcare providers and institutions. The ownership of Pearl Lab further enhances the company’s capacity to deliver advanced genetic testing solutions to clinicians and patients who depend on them.
About Centogene
Centogene is recognized as a global leader in precision medicine and rare disease diagnostics, boasting over 20 years of experience serving patients and healthcare providers in more than 120 countries. The company is powered by one of the world’s most diverse genetic databases and a biodatabank that includes over one million individuals. Centogene provides actionable insights across reproductive health, rare disease diagnosis, and genetic medicine, with its scientific leadership reflected in over 400 peer-reviewed publications.
About Olive Rock Partners
Olive Rock Partners is a private equity firm based in Abu Dhabi, focusing on investing in and developing mid-sized businesses across the GCC. The firm collaborates with management teams to foster growth, operational excellence, and long-term value creation in key sectors, including healthcare.
About Cedro Strategy
Cedro Strategy is a strategic advisory firm dedicated to facilitating growth, partnerships, and value creation across healthcare, investment, and regional business platforms. The firm collaborates with founders, investors, and leadership teams to structure transactions, coordinate commercial, legal, and operational execution, and deliver deals with lasting regional impact.
Media Contacts
Centogene
Ana Esteban
VP Marketing & Customer Experience
Ana.Esteban@centogene.com
Olive Rock Partners
Abdullah Shahin
Founding Partner
Ashahin@oliverockpartners.com
Cedro Strategy
Rayan Salam
Founder & CEO
rsalam@cedrostrategy.co
Source: www.zawya.com
Read all the latest developments and breaking updates in the Latest News section.
Published on 2026-07-09 18:08:00 • By the Editorial Desk
